P2RY6 and Cognitive impairment: Consistent with our result, previous study proved that EA treatment could improve learning-memory ability of the AD mice model and ameliorate poststroke cognitive impairments via inhibition periinfarct astroglia and microglial/macrophage P2 purinoceptors-mediated neuroinflammation [34–36].